这个市发力合成生物制造领域产业基金

Core Viewpoint - The article discusses the implementation of the "Regulations on Promoting the Development of Synthetic Biology Manufacturing Industry in Changde City," which is the first local regulation in the synthetic biology manufacturing field in China, aimed at fostering high-quality development and establishing a national-level industrial cluster [1][2]. Summary by Sections Introduction - The regulations were passed on June 26, 2025, and approved on July 31, 2025, coming into effect immediately upon publication [2][4]. Objectives and Scope - The regulations aim to promote high-quality development in the synthetic biology manufacturing industry, replacing fossil-based materials with bio-based materials and traditional chemical technologies with biotechnology [4][5]. Government Responsibilities - The municipal government is tasked with formulating development plans for the synthetic biology manufacturing industry and integrating it into national economic and social development plans [5][6]. Investment and Innovation - The government will attract projects through various means, including industry chain and capital investment, and will support the establishment of innovation platforms and research centers [6][7]. Support for Enterprises - The regulations encourage the growth of leading enterprises in the synthetic biology sector and support their listing and digital transformation [8][9]. Talent Development - There is a focus on attracting high-level talent and establishing educational institutions related to synthetic biology to cultivate skilled professionals [11][12]. Environmental and Safety Regulations - The regulations emphasize the importance of environmental safety and the establishment of monitoring systems to prevent risks associated with synthetic biology manufacturing [13][14]. Administrative Efficiency - The government aims to streamline administrative processes for synthetic biology enterprises, ensuring efficient approval and support mechanisms [9][10]. Financial Support - The establishment of investment funds and financial policies to support the synthetic biology manufacturing industry is highlighted, along with measures to reduce financing costs for enterprises [12][10].